DRUG · Unmapped registry intervention
COR388 capsule
Find medicine records ·
Find other trials using this name
Clinical trial
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
NCT03823404
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo capsule
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedGAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer Diseaseverified · MONDO: Alzheimer disease
Interventions
COR388 capsuleDRUG
Placebo capsuleDRUG
Sponsors & collaborators
Cortexyme Inc.lead sponsor
Mapped research locations
MiamiFlorida, United States3BarcelonaSpain3HoustonTexas, United States2DallasTexas, United States2PhoenixArizona, United States2BrooklynNew York, United States2Santa AnaCalifornia, United States2MadridSpain1LondonUnited Kingdom1SeattleWashington, United States1TampaFlorida, United States1PortlandOregon, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03823404 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.